| Primary |
| Asthma |
43.2% |
| Product Used For Unknown Indication |
19.1% |
| Drug Use For Unknown Indication |
17.6% |
| Chronic Obstructive Pulmonary Disease |
5.8% |
| Bronchitis |
1.9% |
| Cough |
1.7% |
| Bronchospasm |
1.6% |
| Dyspnoea |
1.5% |
| Emphysema |
1.2% |
| Respiratory Disorder |
1.0% |
| Bronchiolitis |
0.7% |
| Off Label Use |
0.7% |
| Prophylaxis |
0.7% |
| Hypertension |
0.6% |
| Wheezing |
0.6% |
| Asthmatic Crisis |
0.5% |
| Pneumonia |
0.5% |
| Asthma Exercise Induced |
0.4% |
| Multiple Allergies |
0.3% |
| Bronchial Hyperreactivity |
0.3% |
|
| Product Quality Issue |
28.7% |
| Drug Ineffective |
14.5% |
| Pharmaceutical Product Complaint |
9.7% |
| Wheezing |
6.0% |
| Dyspnoea |
5.8% |
| Overdose |
4.1% |
| Asthma |
3.8% |
| Tremor |
3.6% |
| Death |
2.7% |
| Urticaria |
2.7% |
| Drug Administration Error |
2.3% |
| Therapeutic Response Decreased |
2.2% |
| Pneumonia |
2.1% |
| Throat Irritation |
2.1% |
| Cough |
2.0% |
| Vomiting |
1.9% |
| Palpitations |
1.7% |
| Rash |
1.5% |
| Malaise |
1.4% |
| Tachycardia |
1.4% |
|
| Secondary |
| Asthma |
32.7% |
| Product Used For Unknown Indication |
16.9% |
| Drug Use For Unknown Indication |
15.8% |
| Chronic Obstructive Pulmonary Disease |
12.4% |
| Migraine |
4.0% |
| Osteoarthritis |
2.3% |
| Hypertension |
2.1% |
| Dyspnoea |
1.6% |
| Hypersensitivity |
1.5% |
| Depression |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Ill-defined Disorder |
1.2% |
| Bronchitis |
1.2% |
| Epilepsy |
1.1% |
| Diabetes Mellitus |
1.0% |
| Hypothyroidism |
0.9% |
| Deep Vein Thrombosis |
0.8% |
| Pain |
0.7% |
| Prophylaxis |
0.7% |
| Laryngeal Neoplasm |
0.7% |
|
| Dyspnoea |
14.6% |
| Pneumonia |
9.9% |
| Wheezing |
8.5% |
| Death |
8.2% |
| Lower Respiratory Tract Infection |
7.0% |
| Hospitalisation |
5.5% |
| Asthma |
5.1% |
| Tremor |
4.9% |
| Product Quality Issue |
4.4% |
| Chronic Obstructive Pulmonary Disease |
4.0% |
| Drug Ineffective |
3.8% |
| Cerebrovascular Accident |
3.6% |
| Lung Neoplasm Malignant |
3.2% |
| Memory Impairment |
3.2% |
| Adverse Event |
2.7% |
| Malaise |
2.3% |
| Myocardial Infarction |
2.3% |
| Transient Ischaemic Attack |
2.3% |
| Urticaria |
2.3% |
| Respiratory Failure |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.0% |
| Drug Use For Unknown Indication |
19.1% |
| Asthma |
18.2% |
| Chronic Obstructive Pulmonary Disease |
9.1% |
| Hypertension |
4.3% |
| Pain |
3.0% |
| Rheumatoid Arthritis |
2.8% |
| Depression |
2.4% |
| Prophylaxis |
1.9% |
| Crohn's Disease |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Anxiety |
1.6% |
| Osteoporosis |
1.5% |
| Bronchitis |
1.4% |
| Diabetes Mellitus |
1.3% |
| Hypersensitivity |
1.2% |
| Atrial Fibrillation |
1.1% |
| Pneumonia |
0.9% |
| Emphysema |
0.9% |
| Blood Cholesterol Increased |
0.9% |
|
| Vomiting |
11.5% |
| Dyspnoea |
9.5% |
| Pneumonia |
7.8% |
| Wheezing |
7.8% |
| Product Quality Issue |
6.5% |
| Asthma |
6.3% |
| Weight Decreased |
6.1% |
| Weight Increased |
5.3% |
| Death |
4.4% |
| Pain |
4.0% |
| Tremor |
3.8% |
| Urticaria |
3.4% |
| Drug Ineffective |
3.3% |
| Pulmonary Embolism |
3.2% |
| Malaise |
3.1% |
| Nausea |
3.0% |
| Rash |
2.9% |
| Urinary Tract Infection |
2.8% |
| Pyrexia |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
66.7% |
| Atrial Fibrillation |
6.1% |
| Bronchopulmonary Aspergillosis Allergic |
6.1% |
| Chronic Obstructive Pulmonary Disease |
6.1% |
| Myocardial Infarction |
6.1% |
| Bronchitis Chronic |
3.0% |
| Hypertension |
3.0% |
| Hypothyroidism |
3.0% |
|
| Tachycardia |
50.0% |
| Pneumonia |
25.0% |
| Transaminases Increased |
25.0% |
|
